Literature DB >> 17393065

Kinetic properties of recombinant MAO-A on incorporation into phospholipid nanodisks.

F Cruz1, D E Edmondson.   

Abstract

Recent structural studies of human monoamine oxidase A (MAO-A) suggest the entrance to the active site is positioned near the surface of the mitochondrial outer membrane (Colibus et al., 2005). To determine the influence of the phospholipid bilayer on the structure and catalytic properties of MAO in a defined system, we have incorporated the recombinant protein into phospholipid 'nanodiscs' which have been developed by Stephen G. Sligar's group (Denisov et al., 2004). Purified MAO-A incorporates into pre-formed nanodiscs which are approximately 10 nm in diameter and exhibit the thickness expected for a phospholipid bilayer. Nanodisc assemblies of MAO-A are water-soluble, yield increased enzyme stability relative to detergent solutions, are catalytically active, and reactive with acetylenic inhibitors. As compared to detergent-based systems, the catalytic efficiencies (k (cat)/K (m)) of amine oxidation appear to be greater. Also, nanodisc bound MAO-A binds various inhibitors with K (i) values that are 2-4 fold lower than MAO-A in reduced Triton X-100 solutions. Taken together, these data suggest that the membrane environment affects MAO-A catalytic properties for both substrates and reversible inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393065     DOI: 10.1007/s00702-007-0673-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  8 in total

1.  Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors.

Authors:  Frantisek Hubálek; Claudia Binda; Ashraf Khalil; Min Li; Andrea Mattevi; Neal Castagnoli; Dale E Edmondson
Journal:  J Biol Chem       Date:  2005-02-14       Impact factor: 5.157

2.  High-level expression of human liver monoamine oxidase A in Pichia pastoris: comparison with the enzyme expressed in Saccharomyces cerevisiae.

Authors:  Min Li; Frantisĕk Hubálek; Paige Newton-Vinson; Dale E Edmondson
Journal:  Protein Expr Purif       Date:  2002-02       Impact factor: 1.650

3.  Phentermine inhibition of recombinant human liver monoamine oxidases A and B.

Authors:  Ravi K Nandigama; Paige Newton-Vinson; Dale E Edmondson
Journal:  Biochem Pharmacol       Date:  2002-03-01       Impact factor: 5.858

4.  Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B.

Authors:  Luigi De Colibus; Min Li; Claudia Binda; Ariel Lustig; Dale E Edmondson; Andrea Mattevi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

Review 5.  Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain).

Authors:  P C Waldmeier
Journal:  J Neural Transm Suppl       Date:  1987

6.  Directed self-assembly of monodisperse phospholipid bilayer Nanodiscs with controlled size.

Authors:  I G Denisov; Y V Grinkova; A A Lazarides; S G Sligar
Journal:  J Am Chem Soc       Date:  2004-03-24       Impact factor: 15.419

7.  Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues.

Authors:  Frantisek Hubálek; Claudia Binda; Min Li; Yaacov Herzig; Jeffrey Sterling; Moussa B H Youdim; Andrea Mattevi; Dale E Edmondson
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

8.  Co-incorporation of heterologously expressed Arabidopsis cytochrome P450 and P450 reductase into soluble nanoscale lipid bilayers.

Authors:  Hui Duan; Natanya R Civjan; Stephen G Sligar; Mary A Schuler
Journal:  Arch Biochem Biophys       Date:  2004-04-15       Impact factor: 4.013

  8 in total
  9 in total

1.  Cell-free co-expression of functional membrane proteins and apolipoprotein, forming soluble nanolipoprotein particles.

Authors:  Jenny A Cappuccio; Craig D Blanchette; Todd A Sulchek; Erin S Arroyo; Joel M Kralj; Angela K Hinz; Edward A Kuhn; Brett A Chromy; Brent W Segelke; Kenneth J Rothschild; Julia E Fletcher; Federico Katzen; Todd C Peterson; Wieslaw A Kudlicki; Graham Bench; Paul D Hoeprich; Matthew A Coleman
Journal:  Mol Cell Proteomics       Date:  2008-07-04       Impact factor: 5.911

2.  Endothelial nitric oxide synthase oxygenase on lipid nanodiscs: A nano-assembly reflecting native-like function of eNOS.

Authors:  Ghaith AlTawallbeh; Mohammad M Haque; Kiril A Streletzky; Dennis J Stuehr; Mekki Bayachou
Journal:  Biochem Biophys Res Commun       Date:  2017-09-25       Impact factor: 3.575

Review 3.  Nanodiscs in Membrane Biochemistry and Biophysics.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Chem Rev       Date:  2017-02-08       Impact factor: 60.622

Review 4.  On the practical aspects of characterising monoamine oxidase inhibition in vitro.

Authors:  Andrew Holt
Journal:  J Neural Transm (Vienna)       Date:  2018-10-29       Impact factor: 3.575

Review 5.  Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors:  Rona R Ramsay; Alen Albreht
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

Review 6.  Recent advances in nanodisc technology for membrane protein studies (2012-2017).

Authors:  John E Rouck; John E Krapf; Jahnabi Roy; Hannah C Huff; Aditi Das
Journal:  FEBS Lett       Date:  2017-07-06       Impact factor: 4.124

7.  Chapter 11 - Reconstitution of membrane proteins in phospholipid bilayer nanodiscs.

Authors:  T K Ritchie; Y V Grinkova; T H Bayburt; I G Denisov; J K Zolnerciks; W M Atkins; S G Sligar
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

8.  Nanodiscs in the studies of membrane-bound cytochrome P450 enzymes.

Authors:  A Luthra; M Gregory; Y V Grinkova; I G Denisov; S G Sligar
Journal:  Methods Mol Biol       Date:  2013

Review 9.  Nanodiscs: A toolkit for membrane protein science.

Authors:  Stephen G Sligar; Ilia G Denisov
Journal:  Protein Sci       Date:  2020-11-16       Impact factor: 6.993

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.